Nina Arhin, MD
Hematology & Oncology · Hopkinsville, KYNPI 1093164634
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,273 of the $12,234 with a category attached, or 84.0%. 28 manufacturers reported payments, led by Stemline Therapeutics Inc. at 40.8% of the total. 2025 is the largest year on record at $11,052, more than ten times the $232 reported in 2021.
Across 69 payments — averaging $177.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stemline Therapeutics Inc.$5K
- Pfizer$4K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$250
- Tempus AI, Inc$207
- Seagen Inc.$159
- plus $917 from 22 others
What the payments were for
- Consulting fees$10,27384%
- Food & beverage$1,81215%
- Education$1501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stemline Therapeutics Inc. | 3 | $4,986 |
| Pfizer | 5 | $4,164 |
| Johnson & Johnson | 6 | $1,553 |
| Regeneron Healthcare Solutions, Inc. | 3 | $250 |
| Tempus AI, Inc | 5 | $207 |
| Seagen Inc. | 7 | $159 |
| AstraZeneca(2 entities) | 4 | $108 |
| Gilead | 5 | $107 |
| Sobi, Inc | 2 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $80 |
| Novartis | 2 | $61 |
| Merck | 3 | $60 |
| Bristol Myers Squibb | 2 | $46 |
| Pharmaessentia USA Corporation | 2 | $44 |
| Incyte Corporation | 2 | $40 |
| Sanofi | 2 | $39 |
| AbbVie | 1 | $27 |
| Boehringer Ingelheim | 1 | $27 |
| Taiho Oncology, Inc. | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Exelixis Inc. | 1 | $21 |
| Beigene USA, Inc. | 1 | $20 |
| G1 Therapeutics, Inc. | 1 | $19 |
| Beone Medicines USA, Inc. | 1 | $19 |
| GSK | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,234 in reported general payments places this provider in the 75th percentile of 143 hematology & oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Hopkinsville
- Firas BadinLexington$1.6M
- Vivek SharmaLouisville$647K
- Goetz KloeckerLouisville$584K
- Nicola JabbourLexington$563K
- Jeffrey HargisLouisville$450K
- Mohamed HegaziLouisville$380K
- Khuda KhanLouisville$359K
- Jaspreet GrewalLouisville$280K
- Miguel Islas-OhlmayerEdgewood$103K
- Laila AgrawalLouisville$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.